Is HALO stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
We cannot find any recorded dividends paid in our systems.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Halozyme Therapeutics Inc 10 years ago, but if you had invested on Monday 8th of September 2014 when the price was $9.30, you would have made a profit of $49.90 per share or 536.56%
Yes, the average daily trading liquidity for Halozyme Therapeutics Inc is $63.63 million. You should therefore be able to get in and out of your positions relatively fast.
Halozyme Therapeutics Inc has much of the business financed by loans. This puts the company at high risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.28, the company's ability to pay off the debt is normal. Halozyme Therapeutics Inc has a very good net profit margin of 36.94% and should have very high tolerances against inflation.
We have calculated the inflation risk for Halozyme Therapeutics Inc to be low [0.45 out of 1]